Supported by an independent educational grant from Boehringer-Ingelheim.
Bridging the gap between public health and primary care in prevention of cardiometabolic diseases; background of and experiences with the Prevention Consultation in The Netherlands.
Assendelft WJ, Nielen MM, Hettinga DM, et al. Fam Pract. 2012;29 Suppl 1:i126-i131.
Healthy lifestyle through young adulthood and the presence of low cardiovascular disease risk profile in middle age: the Coronary Artery Risk Development in (Young) Adults (CARDIA) study.
Liu K, Daviglus ML, Loria CM, et al. Circulation. 2012;125:996-1004.
Ideal cardiovascular health and mortality from all causes and diseases of the circulatory system among adults in the United States.
Ford ES, Greenlund KJ, Hong Y. Circulation. 2012;125:987-995.
Homocysteine and coronary heart disease: meta-analysis of MTHFR case-control studies, avoiding publication bias.
Clarke R, Bennett DA, Parish S, et al. PLoS Med. 2012;9:e1001177.
Charchar FJ, Bloomer LD, Barnes TA, et al. Lancet. 2011;379:915-922.
Nauman J, Janszky I, Vatten LJ, et al. JAMA. 2011;306:2579-2587.
Benchmarking progress in the implementation of the Fourth Joint Societies' Task Force Guidelines on the Prevention of Cardiovascular Disease in Clinical Practice.
Morgan K, Burke H, McGee H. Eur J Prev Cardiol. 2 012. [Epub ahead of print]
Mustafic H, Jabre P, Caussin C, et al. JAMA. 2012;307:713-721. Review.
Moderate to vigorous physical activity and sedentary time and cardiometabolic risk factors in children and adolescents.
Ekelund U, Luan J, Sherar LB, et al. JAMA. 2012;307:704-712.
Effect of aspirin on vascular and nonvascular outcomes: meta-analysis of randomized controlled trials.
Seshasai SR, Wijesuriya S, Sivakumaran R, et al. Arch Intern Med. 2012;172:209-216.